Faks

Name: Faks
Brand: Faks

AI Native

Just faks it !

Est 2020|Valuation $17.7M|Raised $11.9M|12 Ref Customers

LinkedIn 5K|Web traffic 8K|FTEs 56|HQ Paris, Île-de-France, FR

MarketsSupplier Relationship Management (SRM) and Vendor Management (VRM)

Published Oct 14, 2026

01Common complaints

- You operate outside the vendor’s core geography/ecosystem and your suppliers/labs are not participating. - Your procurement process requires publicly documented SOC 2 or ISO certifications and a detailed trust center that the vendor does not publicly provide. - You require fixed, self-serve pricing for labs/groups rather than custom quotations. - Your pharmacy’s LGO/tools are unsupported and integrations are critical for operations. - You prefer a single system of record (e.g., full consolidation inside your LGO/ERP) rather than adding an overlay platform.

Deal disqualifiers

Operating outside the vendor’s core geography/ecosystem where supplier participation is limited
Procurement requirements that mandate publicly available SOC 2/ISO certificates (unless the vendor can provide documentation under NDA)
Pharmacies with very low dispute/operation volumes (limited ROI)

Publicly observable limitations

Limited public third-party review footprint on mainstream B2B review sites in accessible results, which complicates independent due diligence.
Security certifications (SOC 2, ISO) and detailed compliance artifacts are not clearly documented publicly in the sources reviewed.
Integration performance and lead times depend on third-party vendors (LGOs, professional portals); coverage and timelines vary.

Roadmap / future direction (vendor stated)

Vendor materials indicate development of an AI assistant (Kopilot) and continued expansion of integrations via Konnect, along with European expansion plans.

Caveat: Roadmaps are subject to change and no firm dates were provided in the materials reviewed.

02Why they buy

Differentiators that appear credible

- Workflows tailored to supplier relationship scenarios common in pharmacies (claims, expired returns, commercial operations evidence) rather than generic CRM/ticketing alone. - A platform model intended to connect pharmacies, groups, and labs to support shared workflows; the value of this model depends on actual adoption across ecosystem participants. - Konnect integrations intended to reduce duplicate data entry and support automated reconciliation between participating systems.

Claims that need verification

Vendor-presented ROI claims (for example, specific percentage margin improvements) are not accompanied by methodology or independent validation.
Any assertions of market dominance should be validated with independent market-share research.

03Field reports

What’s available publicly (limitation)

Mainstream B2B review platforms (G2, TrustRadius, Gartner Peer Insights) did not surface product-specific review pages for Faks in accessible search results. Given that limitation, this section relies on:

Vendor-published testimonials on the product site
App Store listing availability (limited ratings shown)
Third-party review aggregators (treated cautiously)

Vendor-published testimonials (examples paraphrased)

- A pharmacy testimonial reports using Faks for disputes, expired items, and commercial operations and describes reduced administrative time and lower losses. - A group testimonial indicates the vendor-reported outcomes include simplified processes, reduced time spent on operational tasks, and better centralization of information. - A laboratory testimonial notes reduced administrative time during sales activities and increased focus on commercial relationship tasks. **Bias note:** These are curated by the vendor and demonstrate intended product value; they are not independent reviews.

App Store evidence (limited)

The App Store listing indicates the app has insufficient ratings in that store to display an overview.
The App Store privacy label lists data categories that may be collected; the store’s label is not an independent verification of practices.

Third-party review-aggregation (use cautiously)

A third-party aggregator displays a limited number of reviews and a very positive summary. Aggregators may repackage store reviews and apply proprietary scoring; methodologies vary and this should be used as a weak signal.

Common reasons to choose (inferred from vendor materials and testimonials)

Centralizing supplier interactions and disputes
Faster dispute/claims tracking (vendor-reported)
Reduced administrative effort through integrations (Konnect)
Improved coordination between pharmacies and groups

Common reasons to leave / not purchase (inferred)

Integrations may not support a pharmacy’s specific LGO/tools
Perceived value may be low if a pharmacy has few commercial operations or disputes
Concerns about granting mandates for synchronization (legal/operational comfort)

Vendor case-study style materials

The vendor-provided materials include customer feedback and embedded videos from pharmacies, provider groups, and labs. Reported outcomes include: - Reduced administrative time - Improved tracking of disputes - Lower reported losses - Better coordination among stakeholders **Critical evaluation:** - Metrics such as amounts saved are not independently validated. - Case studies and testimonials are curated; negative experiences are not shown. - No methodology (baseline, sample size, measurement window) is provided.

Investor commentary as contextual evidence

Investor commentary describing product strategy (for example, expansion from administrative automation into trade management) provides context on direction but is not equivalent to independent case studies.

04Best fit

Best-fit segments

**Pharmacies (France/EU)** - Pharmacies with a meaningful volume of supplier disputes/claims, expired product returns, or participation in commercial operations requiring evidence submission. - Pharmacies seeking to reduce back-office effort and improve reconciliation of operations/invoices. **Pharmacy groups / networks** - Networks that manage promotional operations across multiple member pharmacies and need centralized evidence collection and validation. **Labs** - Laboratories that experience administrative friction in pharmacy interactions (claims, expired returns, promotion evidence collection) and want to reduce field-force administrative time.

Roles/personas

Pharmacy owner/titulaire; pharmacy managers
Back-office/admin staff handling disputes and operations
Group network operations teams
Lab customer service, trade marketing, and field sales leadership

Likely qualification criteria

Uses or can connect supported professional portals/LGOs/accounting tools
Willingness to standardize workflows across staff
Suppliers/labs that will engage through the platform or can be onboarded via existing communication methods

05The pitch

What the product does (core value proposition)

Faks is a B2B SaaS platform (mobile + web) designed to digitize and streamline operational and commercial interactions between pharmacies, pharmacy groups/networks, and pharmaceutical laboratories. It focuses on supplier relationship workflows such as: - Claims / disputes (litiges / réclamations) handling and tracking - Expired items return workflows - Commercial operations (trade plans / promotions) management and evidence submission - Offsets / invoice reconciliation and monitoring - Integrations (Konnect) to connect pharmacy tools (e.g., professional portals, LGO/pharmacy management software, accounting tools, POS/PLV) to reduce manual work These capabilities are described across Faks’ vendor FAQ, marketing, and pricing pages, which break out “Back office” vs “Konnect” features.

Target market and positioning

- **Primary market:** French pharmacy ecosystem (retail pharmacies, groups, pharmaceutical labs), with stated European expansion goals. - **Positioning:** The vendor describes the product as a reference tool for supplier management in pharmacies and intends to create shared workflow layers by encouraging adoption among pharmacies and laboratories. - **International expansion:** The vendor has indicated expansion as a later-phase objective and has referenced other European markets in press coverage.

Get a comprehensive analysis of Faks including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →